Moderna’s mRNA Flu Shot Receives US Government Approval
This week, the FDA granted approval for Moderna’s mRNA flu shot, being marketed as mFlusiva, for people age 50 and up.
https://ronpaulinstitute.org/modernas-mrna-flu-shot-receives-us-government-approval/